Sign in
4

Changes in Ownership

CORCEPT THERAPEUTICS INC Filed Acc 0001193125-26-414688

President, Oncology sold 8,333 shares at an average $116.10 ($967,448)

  • President, Oncology acquired 8,333 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Vieira Roberto Wandenkolk · President, Oncology

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2026-10-02 Exercise or conversion : show line 1 in the form 10b5-1 +8,333 $21.63 $180,243 12,279 D
2026-10-02 Sale : show line 2 in the form 10b5-1 −1,100 $114.52 $125,973 11,179 D
2026-10-02 Sale : show line 3 in the form 10b5-1 −2,086 $115.73 $241,412 9,093 D
2026-10-02 Sale : show line 4 in the form 10b5-1 −5,147 $116.59 $600,063 3,946 D
Open-market sales · 8,333 sh · avg $116.10 · $967,448

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-10-02 Exercise or conversion : show line 5 in the form 10b5-1 Stock option (right to buy) −8,333 133,334 D
Loading xslF345X06/ownership.xml…